Structure Therapeutics Stock (NASDAQ: GPCR)

Dernières nouvelles pour Structure Therapeutics (NASDAQ:GPCR) Stock

STRUCTURE THERAPEUTICS INC

Structure Therapeutics

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics Inc

Treasury yields are climbing again, but this time it&#8217;s not just about inflation or the Fed. It&#8217;s about politics, policy, and a little something <a href="https://www.benzinga.com/markets/bonds">called &#8220;bond vigilance.&#8221;</a>
As President Donald Trump's team flexes its fiscal muscle, pushing tax legislation and emphasizing long-term debt discipline, Wall Street is reading the tea leaves. It&#8217;s sprinting to the front of the yield curve. The BNP Paribas forecast of a 4.25% 10-year yield by the end of 2025 isn't helping investor nerves. 
But for many, the strategy is simple: don't fight the yield, just keep it short.
Read Also: <a href="https://www.benzinga.com/25/05/45654448/bond-market-caught-between-rate-cut-hopes-and-fed-cautionwhat-investors-can-do-now">Bond Market Caught Between Rate-Cut Hopes and Fed Caution—What Investors Can Do Now</a>
<h2 class="wp-block-heading">The $25 Billion Bill Binge</h2>
In 2025 alone, investors have poured over $25 billion into ultra-short bond ETFs like the iShares 0-3 Month Treasury Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGOV#NYSE">SGOV</a>). Inflows into ultra-short bond ETFs were second only to the S&amp;P 500 ETF in new inflows this year, <a href="https://www.cnbc.com/2025/06/01/investors-big-short-treasury-bets-warren-buffett.html">reported</a> CNBC. The SPDR Bloomberg 1-3 Month T-Bill ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIL#NYSE">BIL</a>) and the Vanguard Short-Term Bond Index Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSV#NYSE">BSV</a>) aren't far behind. 
Why the rush into these seemingly sleepy securities? Because they&#8217;re quietly delivering—and investors have noticed.
The 3-month T-Bill now yields over 4.3% &#8211; higher than the 2-year and nearly matching the 10-year, without the duration risk. In a year dominated by uncertainty over the Fed's path, policy whiplash, and geopolitical noise &#8211; stability and predictability are the real alpha. 
<h2 class="wp-block-heading">Warren Buffett Owns 5% Of The Market</h2>
"Long duration just doesn't work right now," says Strategas Securities' Todd Sohn. Warren Buffett seems to agree—his Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) now <a href="https://www.cnbc.com/2025/05/11/berkshire-now-owns-5percent-of-treasury-bill-market-as-buffett-waits-for-prey.html">owns</a> a stunning 5% of the entire short-term T-bill market.
And behind the scenes, Trump's advisors are reportedly focused on keeping long-term rates in check. Treasury Secretary Scott Bessent has signaled a pivot toward more short-term debt issuance and regulatory tweaks to ease pressure on yields. 
BNP Paribas strategist Tim High calls it "bond vigilance," a sort of fiscal hawkishness that aims to calm the bond market without relying on the Fed.
But for the market, that vigilance is turning into a signal. The long end may be politically volatile, but the front end is flush with yield &#8211; and less drama. Investors chasing safety, yield, and clarity have found a perfect storm in 0-3 month paper.
Call it the year of the ultra-short bond: it's catching Buffett's eye, staying on Trump's radar, and winning over Wall Street.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/bonds/25/06/45741095/peter-schiff-calls-out-the-big-short-investor-steve-eisman-for-dismissing-gold-and-us-debt-concerns-the-irony-is-incredible">Peter Schiff Calls Out &#8216;The Big Short&#8217; Investor Steve Eisman For Dismissing Gold And US Debt Concerns: &#8216;The Irony Is Incredible&#8217;</a></li>
</ul>
Photo: Jonathan Weiss/Shutterstock

Bonds

SGOV

Where Warren Buffett Goes, Wall Street Follows: The $25B Bill Binge

<a href="https://www.bloomberg.com/news/articles/2025-06-03/bessent-says-china-has-a-choice-on-being-a-reliable-partner?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-03/bessent-says-china-has-a-choice-on-being-a-reliable-partner?embedded-checkout=true</a>

News

General

'Bessent Says China Has a 'Choice' on Whether or Not to Be a Reliable Partner'- Bloomberg

RBC Capital analyst Ben Hendrix reiterates Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) with a Outperform and maintains $371 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Cigna Group, Maintains $371 Price Target

Ripple's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42783990/heres-how-ripples-rlusd-launch-has-affected-the-xrp-price">U.S. dollar-backed stablecoin RLUSD</a> has received regulatory approval from the Dubai Financial Services Authority (DFSA), allowing it to be used as a legal payment mechanism within the Dubai International Financial Centre (DIFC).
This marks a significant expansion of Ripple's presence in the Middle East as it positions itself to tap into the region's growing demand for regulated digital finance infrastructure.
The DFSA's <a href="https://ripple.com/ripple-press/rlusd-stablecoin-dfsa-approval/">approval</a> means Ripple can now integrate RLUSD into its licensed payment platform within the DIFC.
The move opens the door for over 7,000 companies based in the financial zone to leverage Ripple's stablecoin for cross-border transactions and digital asset services.
Ripple had previously secured authorization to operate in the United Arab Emirates' international payments sector, which handles over $40 billion annually. 
Now, it is enhancing its regional partnerships to solidify adoption. 
Local firms such as the digital bank Zand and the fintech startup Mamo are poised to be among the first to utilize RLUSD in practical applications.
Also Read: <a href="https://www.benzinga.com/markets/25/06/45741645/ethereum-books-record-institutional-inflows-xrp-sees-outflows-what-is-going-on">Ethereum Books Record Institutional Inflows, XRP Sees Outflows: What Is Going On?</a>
The company is also working with Ctrl Alt, a digital infrastructure provider, and the Dubai Land Department on initiatives to tokenize property ownership documents on the XRP Ledger.
RLUSD, launched in December 2024, is fully backed by U.S. dollar reserves and approved by the New York Department of Financial Services. 
It was initially made available on Uphold and later added to platforms like Kraken. 
Currently, RLUSD has a market capitalization of $310 million and competes in a global stablecoin market valued at $250 billion, largely led by Tether's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) and Circle's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>).
Jack McDonald, Ripple's senior vice president of stablecoins, said the DFSA's green light reflects the company's dedication to supporting Dubai's ambitions in digital financial leadership. 
Reece Merrick, Ripple's regional managing director, noted an uptick in institutional interest for crypto-related payment and custody services across the Middle East.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45731315/expert-applauds-secs-protocol-staking-clarity-boosting-crypto-innovation">Expert Applauds SEC&#8217;s Protocol Staking Clarity, Boosting Crypto Innovation</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$USDC

$USDT

$XRP

Ripple's Stablecoin RLUSD Gets Regulatory Nod In Dubai

RBC Capital analyst Nik Modi maintains The Campbell's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) with a Sector Perform and lowers the price target from $44 to $38.

RBC Capital Maintains Sector Perform on The Campbell's, Lowers Price Target to $38

<a href="https://x.com/usambchina/status/1929922392089919653?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/usambchina/status/1929922392089919653?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

U.S. Ambassador to China David Perdue Posts On X "In a meeting today with Central Foreign Affairs Commission Office Director and Foreign Minister Wang Yi, I emphasized President Trump's priorities on trade, fentanyl, and illegal immigration. Communication is vital to the USA-China relationship."

RBC Capital analyst Leonid Timashev maintains Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) with a Outperform and raises the price target from $15 to $16.

CATX

RBC Capital Maintains Outperform on Perspective Therapeutics, Raises Price Target to $16

Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) has outperformed the market over the past 20 years by 4.88% on an annualized basis producing an average annual return of 13.2%. Currently, Raymond James Finl has a market capitalization of $29.34 billion. 
Buying $1000 In RJF: If an investor had bought $1000 of RJF stock 20 years ago, it would be worth $11,792.32 today based on a price of $145.42 for RJF at the time of writing.
<h3>Raymond James Finl's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748964612_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Raymond James Finl 20 Years Ago Would Be Worth Today

Kratos Defense &amp; Security Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) and GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) announced on Tuesday a <a href="https://www.benzinga.com/pressreleases/25/06/g45743410/kratos-and-ge-aerospace-sign-teaming-agreement-expand-small-engine-portfolio-with-new-propulsion-s" target="_blank" rel="noreferrer noopener">formal agreement</a> to develop propulsion technologies for next-generation unmanned aerial systems (UAS) and Collaborative Combat Aircraft (CCA) platforms.
Building on last year&#8217;s memorandum of understanding, the partnership focuses on designing and producing affordable, high-performance engines such as the GEK800 and the more powerful GEK1500, aimed at enhancing U.S. defense capabilities.
Kratos offers over 20 years of experience developing small, cost-effective engines for drones and missiles, while GE Aerospace contributes extensive propulsion expertise and manufacturing scale. Together, they aim to deliver scalable propulsion solutions that meet critical national security needs.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/06/45721053/get-ready-to-pay-the-price-of-tariffs-ge-is-already-passing-costs-to-customers" rel="noreferrer noopener">Get Ready To Pay The Price Of Tariffs: GE Is Already Passing Costs To Customers</a>
Kratos CEO Eric DeMarco stressed affordability and rapid capability delivery as key benefits of the partnership. GE Aerospace Defense President Amy Gowder highlighted the move as a step toward providing adaptable, high-performance propulsion for various unmanned platforms.
The GEK800 engine is currently under development, with work also progressing on the GEK1500. These engines target unmanned and collaborative combat aircraft, offering cost-efficient propulsion for diverse defense missions.
Investors may watch stocks like Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) and Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>), as well as ETFs such as the iShares U.S. Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITA#NYSE">ITA</a>) and SPDR S&amp;P Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XAR#NYSE">XAR</a>).
Price Action: GE shares are trading lower by 0.44% to $246.40, and KTOS stock is up 2.06% at $38.83 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/45745140/trump-taps-japan-to-help-build-175-billion-us-golden-dome-missile-shield-report" target="_blank" rel="noreferrer noopener">Trump Taps Japan To Help Build $175 Billion U.S. &#8216;Golden Dome&#8217; Missile Shield: Report</a></li>
</ul>
Photo by Jonathan Weiss via Shutterstock

Movers

Tech

iShares Dow Jones US Aerospace & Defense Index Fund

KTOS

Kratos, GE Aerospace Expand Small Engine Portfolio With New Propulsion Systems

RBC Capital analyst Rishi Jaluria reiterates Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) with a Outperform and maintains $120 price target.

PEGA

RBC Capital Reiterates Outperform on Pegasystems, Maintains $120 Price Target

<a href="https://www.bloomberg.com/news/articles/2025-06-03/iran-says-us-proposal-for-nuclear-deal-is-ambiguous-and-unclear">https://www.bloomberg.com/news/articles/2025-06-03/iran-says-us-proposal-for-nuclear-deal-is-ambiguous-and-unclear</a>

'Iran Says US Proposal For Nuclear Deal is Ambiguous and Unclear'- Bloomberg

Ciena Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) will report its second-quarter results on Thursday, June 5, before the market opens.
According to Rosenblatt Securities, the company is likely to report healthy results and guidance, slightly ahead of consensus, "driven by strong Cloud Provider revenues and orders and solid Service Provider revenue and orders."
The Ciena Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/628b6bab3547bd000104dc00/mike-genovese">Analyst Mike Genovese</a> reaffirmed a Neutral rating, while raising the price target from $65 to $85.
The Ciena Thesis: The company is likely to report its revenue slightly higher than expectations of $1.09 billion, representing 20% year-on-year growth and 2% sequential growth, Genovese said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Ciena could keep its backlog consistent with the prior quarter, at $2.3 billion, "or even slightly growing backlog, due to strong orders," he added.
The consensus estimates for gross margin, operating margin and earnings are 42.6%, 10.0% and 52 cents per share, all of which "look slightly beatable," the analyst stated.
"We think the company may raise its FY25 revenue guidance slightly above 8% to 11%, but we do not expect it to increase the 3-year guidance yet as it likely works to keep expectations in check until it is closer to launching initial Data Center transceiver products in 2H26," he further wrote.
CIEN Price Action: Shares of Ciena had risen by 0.73% to $82.35 at the time of publication on Tuesday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst">Ciena Posts Solid Q1 Beat, Raise; Guidance Could Be Missed Depending On &#8216;Outcome Of Proposed Tariffs&#8217;</a></li>
</ul>
Image: Shutterstock

Analyst Color

CIEN

Ciena Q2 Preview: Analyst Ups Price Target Ahead Of Likely Beat-And-Raise Quarter

RBC Capital analyst Brian Abrahams reiterates MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Outperform and maintains $67 price target.

MLTX

RBC Capital Reiterates Outperform on MoonLake, Maintains $67 Price Target

The Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), Wall Street's go-to tech fund, just recorded its second-largest monthly inflow on record, as investors chased an impressive rally in the Nasdaq 100 index powered by a trade war truce <a href="https://www.benzinga.com/etfs/new-etfs/25/06/45722678/magnificent-seven-closed-a-blockbuster-may-added-nearly-2-trillion-in-market-value">and Magnificent Seven dominance.</a>
The QQQ ETF pulled in $7.2 billion of net inflows in May, according to TradingView&#8217;s fund flow data. That marks the second-largest monthly inflow in the ETF's 10-year history, only trailing November 2024's $9.2 billion surge that followed Donald Trump's presidential victory.
Fueled by a 9% rally in the Nasdaq 100 — its best month since November 2023 — the fund crossed $330 billion in assets under management, consolidating its position as the fifth-largest ETF globally.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/03104949/image-34-1024x535.png" alt="" class="wp-image-936903" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/03104949/image-34-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/03104949/image-34-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/03104949/image-34-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/03104949/image-34-1536x803.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/03104949/image-34-2048x1070.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">What Sparked The Inflows?</h3>
The rally followed a breakthrough in U.S.-China trade relations. On May 11, both countries agreed to a 90-day trade truce, slashing average tariff rates by 115 percentage points.
U.S. tariffs on Chinese goods dropped from 145% to 30%, while Beijing reduced duties on American imports from 125% to 10%.
"The temporary deal puts greater pressure on the two countries to develop a mutually amicable agreement," LPL Financial chief economist Jeffrey Roach said in a recent note.
The deal provided immediate relief to export-heavy sectors — especially tech hardware, semiconductors and software services — and helped fuel the Nasdaq's broad-based rally.
<h3 class="wp-block-heading">Magnificent Seven&#8217;s Dominance Strengthens</h3>
The Magnificent Seven stocks played a central role in QQQ's surge, continuing the momentum from their historic $1.75 trillion of combined market-cap gain in May.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) jumped 23.5%, becoming the second-best performing Nasdaq 100 stock in the month. 
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) gained 20.9%, while Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>) posted monthly gains of 19.4% and 16.5% respectively.
These megacap tech names are viewed by institutional investors as &#8220;defensive growth proxies&#8221;, according to Goldman Sachs' Ryan Hammond, citing their strong earnings and relevance in AI, cloud computing and enterprise infrastructure.
Roundhill Investments CEO David Mazza, whose firm manages the Roundhill Magnificent Seven ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NYSE">MAGS</a>), said these companies "aren't speculative bets on future adoption," but rather, "staples within global consumers' lives."
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Stock Name</th>
<th>Market Cap on April 30 (B$)</th>
<th>Market Cap on May 31 (B$)</th>
<th>Absolute Change (B$)</th>
<th>% Change in May</th>
</tr>
</thead>
<tbody>
<tr>
<td>Apple</td>
<td>3,192.19</td>
<td>2,999.86</td>
<td>-192.33</td>
<td>-6.0%</td>
</tr>
<tr>
<td>Microsoft</td>
<td>2,937.79</td>
<td>3,421.65</td>
<td>+483.86</td>
<td>+16.5%</td>
</tr>
<tr>
<td>Nvidia</td>
<td>2,657.65</td>
<td>3,297.17</td>
<td>+639.52</td>
<td>+24.1%</td>
</tr>
<tr>
<td>Amazon</td>
<td>1,957.13</td>
<td>2,176.46</td>
<td>+219.33</td>
<td>+11.2%</td>
</tr>
<tr>
<td>Alphabet</td>
<td>1,938.41</td>
<td>2,090.08</td>
<td>+151.67</td>
<td>+7.8%</td>
</tr>
<tr>
<td>Meta Platforms</td>
<td>1,385.92</td>
<td>1,628.00</td>
<td>+242.08</td>
<td>+17.5%</td>
</tr>
<tr>
<td>Tesla</td>
<td>908.83</td>
<td>1,115.93</td>
<td>+207.10</td>
<td>+22.8%</td>
</tr>
<tr>
<td>Total</td>
<td>14,977.92</td>
<td>16,729.15</td>
<td>+1,751.23</td>
<td>+11.7%</td>
</tr>
</tbody>
</table>
</figure>
Read now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/06/45733245/looking-for-summer-seasonal-gains-here-are-10-sp-500-stocks-that-historically-rallied-in-june">Looking For Summer Seasonal Gains? Here Are 10 S&amp;P 500 Stocks That Historically Rallied In June </a></li>
</ul>
Photo: Shutterstock

Broad U.S. Equity ETFs

MAGS

MSFT

NVDA

TSLA

QQQ ETF Just Saw Its Second-Best Month Of Inflows Ever: Here's Why

Politics

Global

JBLU

ULCC

Reuters Cites Filing With Commerce Department Saying U.S. Aerospace Group Warns New Tariffs On Airplanes, Parts Could Put Supply Chain, Aviation Safety At Risk

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0603" target="_blank" rel="noreferrer noopener">&nbsp;and individual tickers.</a>
Here is a look at the most searched stocks on Benzinga Pro for May 2025. Current prices and year-to-date performance are based on May 30 market close prices and do not include dividends.
1. SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)
<ul class="wp-block-list">
<li>Current Price: $589.39</li>
<li>52-Week Range: $481.81 to $613.23</li>
<li>Year-to-Date Return: +0.8%</li>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank">2024 Benzinga Pro Search Rank</a>: 3rd</li>
<li><a href="https://www.benzinga.com/trading-ideas/25/03/44124338/exclusive-februarys-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-palantir-alibaba-nvidia-rank">February</a>/<a href="https://www.benzinga.com/trading-ideas/25/04/44597684/exclusive-marchs-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-nvidia-apple-applovin-stock-rank">March</a>/<a href="https://www.benzinga.com/trading-ideas/25/05/45171636/exclusive-aprils-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-apple-palantir-nvidia-stocks-rank">April </a>2025 Rank: 3rd/2nd/1st</li>
</ul>
2. NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
<ul class="wp-block-list">
<li>Current Price: $135.13</li>
<li>52-Week Range: $86.62 to $153.13</li>
<li>Year-to-Date Return: -2.3%</li>
<li>2024 Benzinga Pro Search Rank: 1st</li>
<li>February/March/April 2025 Rank: 2nd/3rd/2nd</li>
</ul>
3. Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)
<ul class="wp-block-list">
<li>Current Price: $131.78</li>
<li>52-Week Range: $21.00 to $133.49</li>
<li>Year-to-Date Return: +75.3%</li>
<li>2024 Benzinga Pro Search Rank: 7th</li>
<li>February/March/April 2025 Rank: 4th/6th/7th</li>
</ul>
4. Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
<ul class="wp-block-list">
<li>Current Price: $346.46</li>
<li>52-Week Range: $167.41 to $488.54</li>
<li>Year-to-Date Return: -8.7%</li>
<li>2024 Benzinga Pro Search Rank: 2nd</li>
<li>February/March/April 2025 Rank: 5th/1st/3rd</li>
</ul>
5. UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)
<ul class="wp-block-list">
<li>Current Price: $301.91</li>
<li>52-Week Range: $248.88 to $630.73</li>
<li>Year-to-Date Return: -40.2%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>February/March/April 2025 Rank: Not in Top 20/Not in Top 20/Not in Top 20</li>
</ul>
6. Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>)
<ul class="wp-block-list">
<li>Current Price: $7.01</li>
<li>52-Week Range: $0.34 to $13.42</li>
<li>Year-to-Date Return:1,330.6%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>February/March/April 2025 Rank: Not in Top 20/Not in Top 20/Not in Top 20</li>
</ul>
7. Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)
<ul class="wp-block-list">
<li>Current Price: $40.02</li>
<li>52-Week Range: $17.25 to $101.40</li>
<li>Year-to-Date Return: +33.2%</li>
<li>2024 Benzinga Pro Search Rank: 4th</li>
<li>February/March/April 2025 Rank: 1st/9th/Not in Top 20</li>
</ul>
8. D-Wave Quantum Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>)
<ul class="wp-block-list">
<li>Current Price: $16.33</li>
<li>52-Week Range: $0.75 to $19.76</li>
<li>Year-to-Date Return: +69.9% &nbsp;</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>February/March/April 2025 Rank: Not in Top 20/10th/Not in Top 20</li>
</ul>
9. Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>)
<ul class="wp-block-list">
<li>Current Price: $56.56</li>
<li>52-Week Range: $13.47 to $72.98</li>
<li>Year-to-Date Return: +124.4%</li>
<li>2024 Benzinga Pro Search Rank: 5th</li>
<li>February/March/April 2025 Rank: 16th/8th/8th</li>
</ul>
10. Apple Inc (NASDSAQ:AAPL)
<ul class="wp-block-list">
<li>Current Price: $200.85</li>
<li>52-Week Range: $169.21 to $260.10</li>
<li>Year-to-Date Return: -17.6%</li>
<li>2024 Benzinga Pro Search Rank: 5th</li>
<li>February/March/April 2025 Rank: 16th/8th/8th</li>
</ul>
Did You Know?
<ul class="wp-block-list">
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent060325">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
Honorable Mentions:&nbsp;The following stocks were the 11th&nbsp;to 20th&nbsp;most-searched tickers on&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;in May.
11. CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>)
12. Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>)
13. SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>)
14. Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)
15. Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)
16. Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)
17. Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)
18. Siyata Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>)
19. Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>)
20. Pony AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>)
Why It's Important: The SPDR S&amp;P 500 ETF Trust remained the most-searched ticker for a second straight month. Nvidia also ranked second for a second straight month.
New to the top three in May was Palantir, which jumped from seventh place in April to third place in May. The ticker has been popular among investors and ranked in the top 10 each month this year. The third-place ranking is the top for Palantir in 2025.
Tesla fell from third to fourth place, following a fall in April from first to third place. With the highly anticipated launch of Tesla robotaxis in June, the stock could attract more attention and find its way back into the top three spots.
The list of the top 10 most-searched tickers in May included five new stocks compared to the list from April. This included Super Micro Computer jumping back into the top 10 after falling out of the top 20 in April. The stock has been popular among investors this year and saw its highest place on the list since February during the month of May.
D-Wave, a quantum computing stock, also returned to the top 10, ranking 8th in May. Hims &amp; Hers also moved back into the top 10, ranking ninth after previously being outside the top 20 in March and April and ranking 9th in February.
New to the top 10 in May that hadn't been in the top 20 any month this year were United Health and Asset Entities. United Health saw an executive transition announced and was reported to be the subject of a DOJ investigation, a claim the company later denied.
Asset Entities announced a merger and plans to become a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/25/05/45550814/asset-entities-stock-has-skyrocketed-over-the-last-month-whats-going-on">holding treasury company</a>. SharpLink, which ranked 13th, also made a similar announcement but instead of investing in Bitcoin, the company <a href="https://www.benzinga.com/cannabis/25/05/45695750/sharplink-gaming-sbet-stock-soars-over-2600-in-a-week-on-ethereum-treasury-deal">is establishing an </a>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) treasury.
CoreWeave, which went public on March 28, narrowly missed out on the top 10 with an 11th-place ranking for the month of May. The ranking could signal continued popularity for the cloud computing company a month after its IPO.
Advanced Micro Devices, Invesco QQQ Trust and Amazon.com were the three tickers in the 11th to 20th rankings that previously ranked in the top 20 in April, coming in at 18th, 4th and 13th, respectively.
This marked a significant fall for the Invesco QQQ Trust, which ranked fourth in March and April. This could signal less interest in the Nasdaq 100 and technology stocks during the month.
Stay tuned <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0603">to Benzinga Pro </a>for more market-moving news and to track the top tickers. 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/space/25/05/45680115/tesla-the-best-elon-musk-company-84-say-no-these-3-rank-higher">Tesla The Best Elon Musk Company? 84% Say No — These 3 Rank Higher</a></li>
</ul>
Photo: Shutterstock

Topics

Exclusives

$BTC

$ETH

AAPL

AMZN

ASST

COIN

CRWV

GPUS

Hims & Hers Health, Inc. Class A Common Stock

HIMS

OKLO

PLTR

PONY

QBTS

SBET

SMCI

SYTA

EXCLUSIVE: May's 20 Most-Searched Tickers On Benzinga Pro — Where Do Apple, Palantir, CoreWeave, Nvidia Rank?

<a href="https://x.com/CGasparino/status/1929918856677441986" title="https://x.com/CGasparino/status/1929918856677441986">https://x.com/CGasparino/status/1929918856677441986</a>

Contracts

ORCL

SNAP

Charles Gasparino Posts On X "SCOOP: People close to the WhiteHouse tell me the plan regarding TikTok (at least for now) is for President Trump to sign another 90-day operating extension (current one ends June 19) as the future of the Chinese short-video app get enmeshed in the trade US-Chinese trade talks and will likely be used as leverage by the Chinese in crafting a deal. ..."

RBC Capital analyst Ken Herbert maintains GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) with a Outperform and raises the price target from $220 to $275.

RBC Capital Maintains Outperform on GE Aerospace, Raises Price Target to $275

Agreement Expanded for Additional Five Years
PALM BEACH GARDENS, Fla., June 3, 2025 /PRNewswire/ -- Longevity Health, a clinical services company and national Institutional Special Needs Plan (ISNP), today announced that it has extended its partnership with Humana through 2030.
Launched in 2023, the Humana/Longevity collaboration expands special needs health plan offerings for Medicare-eligible individuals living in skilled nursing and senior living facilities. The collaboration between the two companies currently serves members in seven states, and there are plans for significant expansion of new markets, solutions, customer segments and members served.

Longevity Health Holdings, Inc. - Common Stock

XAGE

Longevity Health Extends Strategic Partnership With Humana Through 2030 To Expand Special Needs Medicare Plan Offerings Across Skilled Nursing And Senior Living Facilities, With Plans For Multi-State Growth And Broader Member Reach

RBC Capital analyst Ashish Sabadra maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Sector Perform and raises the price target from $148 to $165.

PAYX

RBC Capital Maintains Sector Perform on Paychex, Raises Price Target to $165

Health Care

Management

Press Releases

Structure Therapeutics Appoints Angus C. Russell to Board of Directors

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity

Comments

Structure Therapeutics

Actualités

Dernières nouvelles pour Structure Therapeutics (NASDAQ:GPCR) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL